{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:33:04Z","timestamp":1793079184185,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xphs.2026.104530","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:28Z","timestamp":1791561268000},"page":"104530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical intraperitoneal delivery: Modulating dilution-induced precipitation from aqueous cosolvent formulations"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6197-981X","authenticated-orcid":false,"given":"Jack","family":"Terry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9368-6196","authenticated-orcid":false,"given":"Josephine","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7074-6007","authenticated-orcid":false,"given":"Josephine","family":"Herrold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3931-1668","authenticated-orcid":false,"given":"Indeewara","family":"Munasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9646-4533","authenticated-orcid":false,"given":"Sara","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-6577","authenticated-orcid":false,"given":"Michael","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104530_bib0001","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2026.104530_bib0002","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acs.bioconjchem.7b00646","article-title":"Advances in polymer design for enhancing oral drug solubility and delivery","volume":"29","author":"Ting","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2026.104530_bib0003","article-title":"Techniques for bioavailability enhancement of BCS class II drugs: a review","author":"Singh","year":"2013","journal-title":"Int J Pharmaceut Chem Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0004","first-page":"32","article-title":"Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures","volume":"11","author":"Jouyban","year":"2008","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?","volume":"37","author":"Al Shoyaib","year":"2020","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104530_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/0023677011911345","volume":"1","author":"Morton","year":"2001","journal-title":"Lab Anim"},{"issue":"3","key":"10.1016\/j.xphs.2026.104530_bib0007","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(25)28988-1","article-title":"The route of absorption of intraperitoneally administered compounds","volume":"178","author":"Lukas","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0008","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5935\/0101-2800.20140013","article-title":"Physiology of fluid and solute transport across the peritoneal membrane","volume":"36","author":"Aguirre","year":"2014","journal-title":"J Bras Nefrol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104530_bib0009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1515\/pp-2016-0015","article-title":"Functional vascular anatomy of the peritoneum in health and disease","volume":"1","author":"Solass","year":"2019","journal-title":"Pleura Perit"},{"issue":"3","key":"10.1016\/j.xphs.2026.104530_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/089686089701700314","article-title":"Peritoneal surface area and its permeability in rats","volume":"17","author":"Kuzlan","year":"1997","journal-title":"Perit Dial Int"},{"issue":"3","key":"10.1016\/j.xphs.2026.104530_bib0011","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/rg.233025712","article-title":"US of the peritoneum","volume":"23","author":"Hanbidge","year":"2003","journal-title":"Radiographics"},{"issue":"5041","key":"10.1016\/j.xphs.2026.104530_bib0012","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/2101123a0","article-title":"Peritoneal fluid volume and the oestrus cycle in mice","volume":"210","author":"Hartveit","year":"1966","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.xphs.2026.104530_bib0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/089686080902902S05","article-title":"How to assess transport in animals?","volume":"29","author":"Rippe","year":"2009","journal-title":"Perit Dial Int"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104530_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.05.049","article-title":"Developing early formulations: practice and perspective","volume":"341","author":"Li","year":"2007","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2012.04.075","article-title":"Development of a precipitation-resistant solution formulation to increase in vivo exposure of a poorly water-soluble compound","volume":"433","author":"Burton","year":"2012","journal-title":"Int J Pharm"},{"issue":"sup109","key":"10.1016\/j.xphs.2026.104530_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097499750042407","article-title":"Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?","volume":"28","author":"Geis","year":"1999","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20755-7","article-title":"Enhancing the solubility of celecoxib via lyophilized solid dispersions using computational and experimental approaches","volume":"15","author":"Rasool","year":"2025","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.xphs.2026.104530_bib0018","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11095-023-03571-4","article-title":"Challenges and opportunities for Celecoxib repurposing","volume":"40","author":"B\u0105k","year":"2023","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104530_bib0019","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcis.2008.05.034","article-title":"Nucleation and crystal growth in supersaturated solutions of a model drug","volume":"325","author":"Lindfors","year":"2008","journal-title":"J Colloid Interface Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104530_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3109\/1061186X.2010.525652","article-title":"Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility","volume":"18","author":"Warren","year":"2010","journal-title":"J Drug Target"},{"issue":"9","key":"10.1016\/j.xphs.2026.104530_bib0021","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2\u20133","key":"10.1016\/j.xphs.2026.104530_bib0022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2008.02.007","article-title":"Comparative interaction of 2-hydroxypropyl-\u03b2-cyclodextrin and sulfobutylether-\u03b2-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions","volume":"34","author":"Brewster","year":"2008","journal-title":"Eur J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104530_bib0023","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0090-9556(24)15094-5","article-title":"Pharmacokinetics, tissue distribution, metabolism, and excretion of Celecoxib in rats","volume":"28","author":"Paulson","year":"2000","journal-title":"Drug Metab Disposit"},{"issue":"5041","key":"10.1016\/j.xphs.2026.104530_bib0024","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/2101123a0","article-title":"Peritoneal fluid volume and the oestrus cycle in mice","volume":"210","author":"Hartveit","year":"1966","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1023228925137","article-title":"Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data","volume":"26","author":"Gagnon","year":"1998","journal-title":"J Pharmacokinet Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0026","doi-asserted-by":"crossref","first-page":"466","DOI":"10.18433\/jpps30611","article-title":"Review of the cosolvency models for predicting solubility in solvent mixtures: an update","volume":"22","author":"Jouyban","year":"2019","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104530_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2019.112129","article-title":"Computational tools for solubility prediction of celecoxib in the binary solvent systems","volume":"299","author":"Rahimpour","year":"2020","journal-title":"J Mol Liq"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.xphs.2026.104530_bib0029","first-page":"117","article-title":"Phase solubility techniques","volume":"4","author":"Connors","year":"1965","journal-title":"Adv Anal Chem Instrum"},{"key":"10.1016\/j.xphs.2026.104530_bib0030","unstructured":"Dhabhar, D.J., Concentrated acetaminophen solution compositions. 1996, Google Patents."},{"key":"10.1016\/j.xphs.2026.104530_bib0031","unstructured":"Gullapalli, R.P., Ibuprofen-containing softgels. 2001, Google Patents."},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5173(98)00386-X","article-title":"Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules","volume":"179","author":"Erlich","year":"1999","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104530_bib0033","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2015.11.015","article-title":"Polyethylene glycols in oral and parenteral formulations\u2013a critical review","volume":"496","author":"Gullapalli","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104530_bib0034","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molliq.2017.08.080","article-title":"Solubilization of celecoxib, lamotrigine and phenytoin using ethanol and a nonionic surfactant","volume":"243","author":"Jouyban-Gharamaleki","year":"2017","journal-title":"J Mol Liq"},{"key":"10.1016\/j.xphs.2026.104530_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.604770","article-title":"Mechanistic understanding from Molecular dynamics simulation in Pharmaceutical research 1: drug delivery","volume":"7","author":"Bunker","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.xphs.2026.104530_bib0036","series-title":"Comprehensive Chirality","first-page":"54","article-title":"10.04 - Physical separations: solid-state forms and habits of chiral substances*","author":"Le Pevelen","year":"2024"},{"issue":"6","key":"10.1016\/j.xphs.2026.104530_bib0037","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/acs.molpharmaceut.7b00121","article-title":"Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations","volume":"14","author":"Stewart","year":"2017","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2026.104530_bib0038","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/pharmaceutics15061601","article-title":"Influence of polyvinylpyrrolidone molecular weight and concentration on the precipitation inhibition of supersaturated solutions of poorly soluble drugs","volume":"15","author":"Odeh","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104530_bib0039","article-title":"Correlating precipitation inhibition efficacy of EUD EPO and PVP K30 on supersaturated solution of atorvastatin calcium with Caco-2 permeability enhancement","volume":"57","author":"Sunnam","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104530_bib0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejpb.2007.05.009","article-title":"Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients","volume":"68","author":"Vogt","year":"2008","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1016\/j.xphs.2026.104530_bib0041","article-title":"Physical mixing of water-soluble polymers with amorphous solid dispersions based on L-HPC: supporting supersaturation and improving the kinetic solubility profile","volume":"106","author":"Amaral","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104530_bib0042","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/03639040801929273","article-title":"Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition","volume":"34","author":"Miller","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/DDC-120027506","article-title":"Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions","volume":"30","author":"Tanno","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104530_bib0044","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jps.2600720920","article-title":"Interaction of povidone with aromatic compounds IV: effects of macromolecule molecular weight, solvent dielectric constant, and ligand solubility on complex formation","volume":"72","author":"Plaizier-Vercammen","year":"1983","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104530_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2003.07.010","article-title":"Establishment of new preparation method for solid dispersion formulation of tacrolimus","volume":"267","author":"Yamashita","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104530_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2025.100252","article-title":"Recent progress in supersaturation-based SNEDDS: formulation, mechanism, and biopharmaceutical performance","volume":"25","author":"Priani","year":"2025","journal-title":"OpenNano"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:00:13Z","timestamp":1793077213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0022354926003801"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104530","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical intraperitoneal delivery: Modulating dilution-induced precipitation from aqueous cosolvent formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104530"}}